Maria Messina

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Early effects of first-line treatment with anti-interleukin-6 receptor antibody tocilizumab for chronic active antibody-mediated rejection in kidney transplantation.

Early effects of first-line treatment with anti-interleukin-6 receptor antibody tocilizumab for chronic active antibody-mediated rejection in kidney transplantation.

Journal: Clinical transplantation

Published: January 10, 2020

Relationship between early proteinuria and long term outcome of kidney transplanted patients from different decades of donor age.

Relationship between early proteinuria and long term outcome of kidney transplanted patients from different decades of donor age.

Journal: BMC nephrology

Published: July 12, 2019

Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results.

Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results.

Journal: World journal of transplantation

Published: May 02, 2018

Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.

Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.

Journal: Clinical transplantation

Published: January 14, 2018

Detection of Angiotensin II type I-receptor antibodies in transplant glomerulopathy.

Detection of Angiotensin II type I-receptor antibodies in transplant glomerulopathy.

Journal: Clinical transplantation

Published: December 29, 2017

Long-Term Outcomes and Discard Rate of Kidneys by Decade of Extended Criteria Donor Age.

Long-Term Outcomes and Discard Rate of Kidneys by Decade of Extended Criteria Donor Age.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: June 20, 2016

Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.

Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.

Journal: Journal of nephrology

Published: January 19, 2016

Update on the treatment of focal segmental glomerulosclerosis in renal transplantation.

Update on the treatment of focal segmental glomerulosclerosis in renal transplantation.

Journal: World journal of transplantation

Published: November 15, 2015

Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy.

Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy.

Journal: Transplant immunology

Published: April 27, 2015

Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.

Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.

Journal: The new microbiologica

Published: January 23, 2015

Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors.

Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors.

Journal: PloS one

Published: January 13, 2015

mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.

mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.

Journal: Journal of nephrology

Published: October 09, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026